4-80072228-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_058172.6(ANTXR2):c.152+181C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.758 in 152,048 control chromosomes in the GnomAD database, including 44,609 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.76 ( 44609 hom., cov: 31)
Consequence
ANTXR2
NM_058172.6 intron
NM_058172.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.52
Publications
5 publications found
Genes affected
ANTXR2 (HGNC:21732): (ANTXR cell adhesion molecule 2) This gene encodes a receptor for anthrax toxin. The protein binds to collagen IV and laminin, suggesting that it may be involved in extracellular matrix adhesion. Mutations in this gene cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
ANTXR2 Gene-Disease associations (from GenCC):
- hyaline fibromatosis syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- juvenile hyaline fibromatosisInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- infantile systemic hyalinosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 4-80072228-G-C is Benign according to our data. Variant chr4-80072228-G-C is described in ClinVar as Benign. ClinVar VariationId is 1279994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.839 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ANTXR2 | NM_058172.6 | c.152+181C>G | intron_variant | Intron 1 of 16 | ENST00000403729.7 | NP_477520.2 | ||
| ANTXR2 | NM_001145794.2 | c.152+181C>G | intron_variant | Intron 1 of 15 | NP_001139266.1 | |||
| ANTXR2 | NM_001286780.2 | c.-79-574C>G | intron_variant | Intron 1 of 16 | NP_001273709.1 | |||
| ANTXR2 | NM_001286781.2 | c.-80+481C>G | intron_variant | Intron 1 of 16 | NP_001273710.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ANTXR2 | ENST00000403729.7 | c.152+181C>G | intron_variant | Intron 1 of 16 | 1 | NM_058172.6 | ENSP00000385575.2 |
Frequencies
GnomAD3 genomes AF: 0.758 AC: 115168AN: 151930Hom.: 44582 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
115168
AN:
151930
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.758 AC: 115244AN: 152048Hom.: 44609 Cov.: 31 AF XY: 0.752 AC XY: 55894AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
115244
AN:
152048
Hom.:
Cov.:
31
AF XY:
AC XY:
55894
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
27769
AN:
41468
American (AMR)
AF:
AC:
10179
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
3041
AN:
3470
East Asian (EAS)
AF:
AC:
2108
AN:
5120
South Asian (SAS)
AF:
AC:
3976
AN:
4816
European-Finnish (FIN)
AF:
AC:
7954
AN:
10588
Middle Eastern (MID)
AF:
AC:
260
AN:
292
European-Non Finnish (NFE)
AF:
AC:
57431
AN:
67988
Other (OTH)
AF:
AC:
1635
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1335
2669
4004
5338
6673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2190
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.